-
Supply Chain Optimization in the Pharmaceutical Industry – Drivers and Challenges
Tuesday, November 13
2:00 pm – 4:30 pm
Symposium
ACPE #073-999-07-562-L04
Pharmaceutical companies are faced with pricing pressures, shrinking margins and aggressive product development and registration timelines. Manufacturing and distribution costs are becoming a bigger component of overall costs in large pharmaceutical manufacturing and contract manufacturing companies. In an effort to improve their overall efficiency and realize potential savings, these companies are seeking to optimize their supply chains. Approaches taken to achieve this objective include consolidation of manufacturing sites and distribution networks and the adoption of high throughput manufacturing platforms. Mergers and acquisitions add to the complexity of integrating the supply chains of the legacy companies. These changes have an impact on how processes are developed and transferred across sites that can have different manufacturing equipment and process trains. The drivers for supply chain optimization and the approaches taken by ‘big pharma’ and contract manufacturers to streamline their supply chains and address the ensuing challenges are discussed in this symposium.
Moderators
Vidya Swaminathan, Ph.D.
Pfizer, Inc.
Stephen Closs
Patheon, Inc.
Supply Chain Opportunities in the Pharmaceutical Industry – Drivers, Challenges and Opportunities
Ray Manganelli, Ph.D.
Tunnell Consulting, Inc.
Supply Chain Management for the Lifecycle of Product Development – Good Relationships are Key
Charles Younger, Ph.D.
Patheon, Inc.
Managing Process Development and Technology Transfer Challenges
Nithin Pathak, Ph.D.
Pfizer, Inc.
Emerging Technologies for Addressing Vulnerabilities in the Pharmaceutical Supply Chain
Panel Discussion
Back to Top